|
|
|
|
| LEADER |
00000nam a2200000 a 4500 |
| 001 |
ELB178416 |
| 003 |
FINmELB |
| 005 |
20200520144314.0 |
| 006 |
m o d | |
| 007 |
cr cn||||||||| |
| 008 |
070610s2007 enk sb 001 0 eng d |
| 020 |
|
|
|z 9780470319383 (alk. paper)
|
| 020 |
|
|
|z 9780470518144
|
| 035 |
|
|
|a (OCoLC)144568198
|
| 040 |
|
|
|a FINmELB
|c FINmELB
|d FINmELB
|
| 050 |
|
4 |
|a RC694.3
|b .A77 2007
|
| 082 |
0 |
4 |
|a 616.1/42
|2 22
|
| 100 |
1 |
|
|a Askari, Arman T.
|
| 245 |
1 |
0 |
|a Management strategies in antithrombotic therapy
|h [electronic resource] /
|c by Arman Askari and Adrian W. Messerli.
|
| 260 |
|
|
|a Chichester ;
|a Hoboken, N.J. :
|b John Wiley and Sons,
|c c2007.
|
| 300 |
|
|
|a 350 p.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Thrombosis and antithrombotics in vascular disease -- Aspirin -- Thienopyridines, ticlopidine, and clopidogrel -- Platelet glycoprotein IIb/IIIa inhibitors -- Unfractionated heparin -- Low-molecular-weight heparins -- Direct thrombin inhibitors -- Fibrinolytic agents -- Acute ST-segment elevation myocardial infarction -- Acute coronary syndromes / non-ST-segment elevation myocardial infarction -- Anticoagulation strategies for patients undergoing percutaneous coronary intervention -- Venous thromboembolic disease -- Heparin-induced thrombocytopenia.
|
| 588 |
|
|
|a Description based on metadata supplied by the publisher and other sources.
|
| 590 |
|
|
|a Electronic reproduction. Santa Fe, Arg.: elibro, 2021. Available via World Wide Web. Access may be limited to eLibro affiliated libraries.
|
| 650 |
|
0 |
|a Thrombolytic therapy.
|
| 650 |
|
0 |
|a Thrombosis
|x Treatment.
|
| 650 |
|
0 |
|a Fibrinolytic agents.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Messerli, Adrian W.
|
| 797 |
2 |
|
|a elibro, Corp.
|
| 856 |
4 |
0 |
|u https://elibro.uam.elogim.com/ereader/bidiuam/178416
|z Texto completo
|
| 950 |
|
|
|a eLibro English
|
